May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

An interval walking exercise typically consists of three to five minutes of walking at a moderate pace interspersed with 30- ...

Can a diet pill treat cancer? There is fresh evidence that indicates type 2 diabetes and obesity medications GLP-1 receptor ...

While other treatment strategies most often come into play, diet and exercise are the principal staples in the fight against weight gain and obesity. The role of proper nutrition in maintaining a ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

In today’s fast-paced world, achieving and maintaining a healthy weight can often feel daunting. Many individuals find ...

Stocks closed solidly higher on Friday, pushing major indexes to big weekly gains for the third time in the last four weeks.

Country music hitmaker Nate Smith tells PEOPLE he lost 55 lbs. after making changes to his lifestyle when he realized he was ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Experts warn the viral #SkinnyTok weight-loss hashtag could be a “guidebook” for people with eating disorders or people ...